- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有36家主力机构披露2025-12-31报告期持股数据，持仓量总计4246.22万股，占流通A股14.53%
- 波段诊断：
-
技术面诊股
诊断结果：6.0技术面打败了77%的股票
技术面评分前10的股票
近期的平均成本为9.25元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为9.25元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.25","date":1787040976,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2026.08.19","stock":"-2.34","trade":null,"ind":"-5.01"},{"date":"2026.08.18","stock":"0.53","trade":null,"ind":"-0.56"},{"date":"2026.08.17","stock":"-0.74","trade":null,"ind":"2.44"},{"date":"2026.08.14","stock":"1.73","trade":null,"ind":"0.45"},{"date":"2026.08.13","stock":"1.42","trade":null,"ind":"-0.87"},{"date":"2026.08.12","stock":"0.33","trade":null,"ind":"1.09"},{"date":"2026.08.11","stock":"-1.41","trade":null,"ind":"-0.40"},{"date":"2026.08.10","stock":"-0.11","trade":null,"ind":"0.04"},{"date":"2026.08.07","stock":"6.44","trade":null,"ind":"1.42"},{"date":"2026.08.06","stock":"-0.11","trade":null,"ind":"-0.24"},{"date":"2026.08.05","stock":"-1.47","trade":null,"ind":"1.86"},{"date":"2026.08.04","stock":"0.57","trade":null,"ind":"3.25"},{"date":"2026.08.03","stock":"1.62","trade":null,"ind":"-0.96"},{"date":"2026.07.31","stock":"1.41","trade":null,"ind":"2.21"},{"date":"2026.07.30","stock":"0.95","trade":null,"ind":"-2.73"},{"date":"2026.07.29","stock":"1.32","trade":null,"ind":"1.10"},{"date":"2026.07.28","stock":"-0.12","trade":null,"ind":"-4.52"},{"date":"2026.07.27","stock":"2.96","trade":null,"ind":"2.72"},{"date":"2026.07.24","stock":"-3.23","trade":null,"ind":"-2.47"},{"date":"2026.07.23","stock":"1.45","trade":null,"ind":"0.44"},{"date":"2026.07.22","stock":"-1.20","trade":null,"ind":"-1.42"}]
美康生物,深证成指,医疗器械指数
压力支撑
该股压力位为9.26元，支撑位为9.12元。
[{"text":"\u538b\u529b\u4f4d","value":"9.26","date":1787068800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.12","date":1787068800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.6资金面打败了62%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：08月19日 20:30
| 机构今日流向(万元) | -1040.51 | 机构5日流向(万元) | -2890.92 |
| 机构10日流向(万元) | -5198.58 | 机构20日流向(万元) | -5686.51 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加85.62万股，其中基金净增仓4家，主力净增仓1家，有一定的中长期投资价值。
截止2025-12-31，共36家主力机构（基金35家，一般法人1家），持仓量总计4246.22万股，占流通A股14.53%
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 93.41万股
减仓：8家 ，减持 7.07万股
新出现在主力名单中：14家 ，持有18.97万股
从主力名单中消失：13家 ，原持有19.69万股
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 93.41万股
减仓：8家 ，减持 7.07万股
新出现在主力名单中：14家 ，持有18.97万股
从主力名单中消失：13家 ，原持有19.69万股
消息面诊股
诊断结果：6.2消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 国家医保检验立项指南落地 美康生物质谱与VAP血脂
2026-08-18 - 火了！政策重磅利好！质谱收费通道全面打通！
2026-08-17 - 美康生物开拓美洲新机遇
2026-07-31 - 肺癌血清学标志物检测：从辅助诊断到全程管理临床工具
2026-07-17 - 美康生物闪耀 WHX Bangkok 2026，聚
2026-07-13 - 《疾病预防控制“十五五”规划》推进 美康生物卡位公
2026-07-10 - 美康生物MS-P7流水线：重构实验室自动化创新范式
2026-07-06 - 2026年6月抗体专利盘点：从ADC工艺革新到诊断
2026-06-29 - 美康生物：目前公司生产经营活动一切正常，各项业务稳
2026-06-26 - 美康生物再添硬核器械 子公司离子阱质谱仪获批医疗器
2026-06-17
消息列表
| 一般消息 | 募资投向 | 2026-06-01 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-29 |
| 利好 | 分红转增 | 10派0.33元(含税) | 2026-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-14 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-14 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了2%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.08.19","price":"-5.01","value":null},{"date":"2026.08.18","price":"-0.56","value":null},{"date":"2026.08.17","price":"2.44","value":null},{"date":"2026.08.14","price":"0.45","value":null},{"date":"2026.08.13","price":"-0.87","value":null},{"date":"2026.08.12","price":"1.09","value":null},{"date":"2026.08.11","price":"-0.40","value":null},{"date":"2026.08.10","price":"0.04","value":null},{"date":"2026.08.07","price":"1.42","value":null},{"date":"2026.08.06","price":"-0.24","value":null},{"date":"2026.08.05","price":"1.86","value":null},{"date":"2026.08.04","price":"3.25","value":null},{"date":"2026.08.03","price":"-0.96","value":null},{"date":"2026.07.31","price":"2.21","value":null},{"date":"2026.07.30","price":"-2.73","value":null},{"date":"2026.07.29","price":"1.10","value":null},{"date":"2026.07.28","price":"-4.52","value":null},{"date":"2026.07.27","price":"2.72","value":null},{"date":"2026.07.24","price":"-2.47","value":null},{"date":"2026.07.23","price":"0.44","value":null},{"date":"2026.07.22","price":"-1.42","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 五洲医疗 | 120.98% | 2.95% | 4.5分 |
| 2 | 戴维医疗 | 50.76% | 23.46% | 4.9分 |
| 3 | 南卫股份 | 47.21% | 5.76% | 5.1分 |
| 4 | 中红医疗 | 43.07% | -6.09% | 5.0分 |
| 5 | 采纳股份 | 38.51% | 0.12% | 5.4分 |
| 6 | 洁特生物 | 37.86% | -10.57% | 5.8分 |
| 8 | 睿昂基因 | 25.53% | -2.12% | 5.0分 |
| 10 | 超研股份 | 22.83% | -1.36% | 6.0分 |
| 12 | 爱威科技 | 21.93% | -2.08% | 5.3分 |
| 14 | 港通医疗 | 20.29% | -0.26% | 5.1分 |
| 16 | 安必平 | 19.02% | -2.45% | 5.0分 |
| 18 | 康众医疗 | 17.29% | -15.46% | 4.7分 |
| 20 | 尚荣医疗 | 16.97% | 0.62% | 4.5分 |
| 22 | 正川股份 | 16.64% | -4.69% | 5.4分 |
| 24 | 仁度生物 | 16.30% | -4.75% | 4.8分 |
| 26 | 黄山胶囊 | 15.78% | -1.51% | 5.3分 |
| 28 | 易瑞生物 | 15.59% | -2.08% | 5.1分 |
| 30 | 宝莱特 | 15.40% | 1.42% | 3.9分 |
| 32 | 华强科技 | 15.23% | -6.25% | 4.1分 |
| 34 | 拱东医疗 | 14.67% | 1.52% | 6.3分 |
| 36 | 海泰新光 | 14.44% | 8.99% | 5.1分 |
| 38 | 天臣医疗 | 14.31% | -3.38% | 5.6分 |
| 40 | 科华生物 | 13.64% | -2.48% | 5.3分 |
| 42 | - | 13.45% | 0.80% | 分 |
| 44 | 天益医疗 | 13.23% | -0.37% | 5.5分 |
| 46 | 华兰股份 | 12.10% | -10.63% | 5.2分 |
| 48 | ST凯利 | 11.41% | -6.09% | 4.7分 |
| 50 | 济高发展 | 10.96% | -4.89% | 3.9分 |
| 52 | 新产业 | 10.80% | 11.77% | 6.2分 |
| 54 | 科美诊断 | 10.32% | -1.43% | 5.1分 |
| 56 | 奥泰生物 | 9.42% | -3.65% | 4.7分 |
| 58 | *ST明德 | 8.74% | -1.70% | 4.6分 |
| 60 | 山外山 | 8.62% | -2.43% | 5.2分 |
| 62 | 奕瑞科技 | 8.33% | 1.89% | 5.9分 |
| 64 | - | 8.13% | -3.47% | 分 |
| 66 | 利德曼 | 7.45% | -3.51% | 4.6分 |
| 68 | 英诺特 | 6.68% | -15.39% | 4.0分 |
| 70 | 安旭生物 | 6.33% | -0.99% | 5.0分 |
| 72 | 威高血净 | 5.89% | -3.57% | 5.2分 |
| 74 | 奥美医疗 | 5.71% | -2.63% | 5.7分 |
| 76 | 健尔康 | 4.99% | -2.23% | 5.1分 |
| 78 | 健信超导 | 4.84% | -7.19% | 4.8分 |
| 80 | 春立医疗 | 4.73% | -6.01% | 4.8分 |
| 82 | 威高骨科 | 4.67% | -3.68% | 5.2分 |
| 84 | 迈克生物 | 4.45% | -3.27% | 4.6分 |
| 86 | 英科医疗 | 4.24% | -2.12% | 5.0分 |
| 88 | 亚辉龙 | 4.22% | -1.57% | 5.2分 |
| 90 | 圣湘生物 | 4.13% | 1.69% | 5.4分 |
| 92 | 康德莱 | 4.04% | -1.84% | 5.3分 |
| 94 | 安图生物 | 3.88% | 5.20% | 5.9分 |
| 96 | 九强生物 | 3.57% | -2.52% | 4.7分 |
| 98 | 开立医疗 | 3.15% | -3.81% | 4.8分 |
| 100 | 东方生物 | 2.54% | -3.26% | 4.5分 |
| 102 | - | 2.15% | -5.95% | 分 |
| 104 | - | 2.09% | -6.49% | 分 |
| 106 | 万孚生物 | 1.74% | -4.07% | 4.0分 |
| 108 | - | 0.70% | -4.55% | 分 |
| 110 | 三诺生物 | 0.00% | -4.25% | 5.2分 |
| 112 | 大博医疗 | -0.32% | -3.81% | 5.9分 |
| 114 | 硕世生物 | -0.56% | -4.75% | 4.9分 |
| 116 | 欧普康视 | -0.73% | -6.41% | 4.2分 |
| 118 | 迈瑞医疗 | -1.08% | -1.93% | 5.5分 |
| 120 | 爱博医疗 | -1.32% | -3.62% | 5.0分 |
| 122 | 佰仁医疗 | -1.67% | -4.17% | 5.1分 |
| 124 | 昊海生科 | -3.05% | -4.57% | 4.8分 |
| 126 | 济民健康 | -3.88% | -6.65% | 4.1分 |
| 128 | 联影医疗 | -4.56% | -1.67% | 5.2分 |
| 130 | 乐普医疗 | -5.43% | -6.15% | 4.5分 |
| 132 | 爱迪特 | -6.30% | -5.22% | 5.2分 |
| 134 | 可孚医疗 | -8.17% | -2.76% | 5.3分 |
| 136 | - | -12.56% | -7.23% | 分 |
| 138 | 热景生物 | -15.48% | -5.33% | 4.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/244 ， 94/244。
[{"date":"2026-03-31","value":"1.14","vol":"1.12"},{"date":"2025-12-31","value":"2.14","vol":"2.37"},{"date":"2025-09-30","value":"2.05","vol":"3.06"},{"date":"2025-06-30","value":"1.93","vol":"2.40"},{"date":"2025-03-31","value":"1.03","vol":"1.17"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.14 | 2.14 | 2.05 | 1.93 | 1.03 |
| 行业(%) | 1.12 | 2.37 | 3.06 | 2.40 | 1.17 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"38.45","vol":"52.12"},{"date":"2025-12-31","value":"36.80","vol":"51.82"},{"date":"2025-09-30","value":"39.64","vol":"52.03"},{"date":"2025-06-30","value":"40.80","vol":"52.36"},{"date":"2025-03-31","value":"39.75","vol":"51.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
38.45 | 36.80 | 39.64 | 40.80 | 39.75 |
| 行业(%) | 52.12 | 51.82 | 52.03 | 52.36 | 51.96 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 74/244 ， 49/244。
[{"date":"2026-03-31","value":"0.53","vol":"5.59"},{"date":"2025-12-31","value":"-11.67","vol":"1.01"},{"date":"2025-09-30","value":"-19.27","vol":"0.11"},{"date":"2025-06-30","value":"-22.43","vol":"-1.37"},{"date":"2025-03-31","value":"-22.32","vol":"-0.45"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.53 | -11.67 | -19.27 | -22.43 | -22.32 |
| 行业(%) | 5.59 | 1.01 | 0.11 | -1.37 | -0.45 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"11.08","vol":"-20.93"},{"date":"2025-12-31","value":"-75.50","vol":"-33.44"},{"date":"2025-09-30","value":"-73.02","vol":"-15.21"},{"date":"2025-06-30","value":"-68.15","vol":"-17.88"},{"date":"2025-03-31","value":"-61.57","vol":"-2.61"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
11.08 | -75.50 | -73.02 | -68.15 | -61.57 |
| 行业(%) | -20.93 | -33.44 | -15.21 | -17.88 | -2.61 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 35/244 ， 17/244。
[{"date":"2026-03-31","value":"0.10","vol":"0.08"},{"date":"2025-12-31","value":"0.42","vol":"0.35"},{"date":"2025-09-30","value":"0.31","vol":"0.25"},{"date":"2025-06-30","value":"0.20","vol":"0.17"},{"date":"2025-03-31","value":"0.10","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.42 | 0.31 | 0.20 | 0.10 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.96","vol":"0.55"},{"date":"2025-12-31","value":"3.76","vol":"2.33"},{"date":"2025-09-30","value":"2.54","vol":"1.66"},{"date":"2025-06-30","value":"1.60","vol":"1.12"},{"date":"2025-03-31","value":"0.81","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.96 | 3.76 | 2.54 | 1.60 | 0.81 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-15.38","vol":"-0.33"},{"date":"2025-12-31","value":"30.15","vol":"32.14"},{"date":"2025-09-30","value":"12.19","vol":"14.86"},{"date":"2025-06-30","value":"39.36","vol":"15.69"},{"date":"2025-03-31","value":"-12.37","vol":"4.55"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -15.38 | 30.15 | 12.19 | 39.36 | -12.37 |
| 行业 | -0.33 | 32.14 | 14.86 | 15.69 | 4.55 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.03","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.68","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.03 | - | 0.68 | - |
| 行业 | 0.00 | 1.62 | 0.01 | 1.58 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 54/244 ， 59/244。
[{"date":"2026-03-31","value":"3.46","vol":"6.17"},{"date":"2025-12-31","value":"3.03","vol":"5.27"},{"date":"2025-09-30","value":"3.12","vol":"5.64"},{"date":"2025-06-30","value":"3.07","vol":"5.45"},{"date":"2025-03-31","value":"3.29","vol":"5.78"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.46 | 3.03 | 3.12 | 3.07 | 3.29 |
| 行业 | 6.17 | 5.27 | 5.64 | 5.45 | 5.78 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.71","vol":"5.04"},{"date":"2025-12-31","value":"2.43","vol":"4.13"},{"date":"2025-09-30","value":"2.46","vol":"4.49"},{"date":"2025-06-30","value":"2.38","vol":"4.34"},{"date":"2025-03-31","value":"2.61","vol":"4.68"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.71 | 2.43 | 2.46 | 2.38 | 2.61 |
| 行业 | 5.04 | 4.13 | 4.49 | 4.34 | 4.68 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 69/244 ， 70/244。
[{"date":"2026-03-31","value":"17.05","vol":"22.26"},{"date":"2025-12-31","value":"19.32","vol":"23.19"},{"date":"2025-09-30","value":"19.34","vol":"22.23"},{"date":"2025-06-30","value":"19.42","vol":"22.18"},{"date":"2025-03-31","value":"17.41","vol":"21.17"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.05 | 19.32 | 19.34 | 19.42 | 17.41 |
| 行业(%) | 22.26 | 23.19 | 22.23 | 22.18 | 21.17 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.21","vol":"0.40"},{"date":"2025-12-31","value":"0.24","vol":"0.41"},{"date":"2025-09-30","value":"0.24","vol":"0.72"},{"date":"2025-06-30","value":"0.24","vol":"0.58"},{"date":"2025-03-31","value":"0.21","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.21 | 0.24 | 0.24 | 0.24 | 0.21 |
| 行业(%) | 0.40 | 0.41 | 0.72 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.99","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.57","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.58","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.63","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]